الصفحة الرئيسية>>Signaling Pathways>> Chromatin/Epigenetics>> PAD>>BB-Cl-Amidine hydrochloride

BB-Cl-Amidine hydrochloride

رقم الكتالوجGC35480

هيدروكلوريد BB-Cl-Amidine هو مثبط للبيبتيدلارجينين deminase (PAD)

Products are for research use only. Not for human use. We do not sell to patients.

BB-Cl-Amidine hydrochloride التركيب الكيميائي

Cas No.: 2436747-41-8

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
151٫00
متوفر
1mg
70٫00
متوفر
5mg
139٫00
متوفر
10mg
241٫00
متوفر
25mg
547٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

BB-Cl-Amidine hydrochloride is a peptidylarginine deminase (PAD) inhibitor. PAD[1].

Treatment with BB-Cl-amidine subtly reduces splenomegaly in MRL/lpr mice, while there is a trend towards increased circulating levels of anti-NET antibodies with PAD inhibitor treatment. However, neither PAD inhibitor affected body weight or total IgG levels. Indeed, treatment with both Cl-amidine and BB-Cl-amidine significantly improves endothelium-dependent vasorelaxation. The BB-Cl-amidine group also shows a strong trend towards downregulation of IRGs. Treatment with either Cl-amidine or BB-Cl-amidine significantly improves muzzle alopecia, in many cases preventing it entirely[1]. Animal Model: MRL/lpr mice[1].

[1]. Knight JS, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis. 2015 Dec;74(12):2199-206.

مراجعات

Review for BB-Cl-Amidine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for BB-Cl-Amidine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.